DO1
CAS No. 2581-69-3
DO1( Disperse Orange 1 )
Catalog No. M21106 CAS No. 2581-69-3
DO1 is an anti-amyloid agent which potently delays both seeded and non-seeded Aβ42 polymerization at substoichiometric concentrations.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 10MG | 29 | In Stock |
|
| 25MG | 41 | In Stock |
|
| 50MG | 77 | In Stock |
|
| 100MG | 116 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 290 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDO1
-
NoteResearch use only, not for human use.
-
Brief DescriptionDO1 is an anti-amyloid agent which potently delays both seeded and non-seeded Aβ42 polymerization at substoichiometric concentrations.
-
DescriptionDO1 is an anti-amyloid agent which potently delays both seeded and non-seeded Aβ42 polymerization at substoichiometric concentrations.
-
In Vitro——
-
In Vivo——
-
SynonymsDisperse Orange 1
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2581-69-3
-
Formula Weight318.33
-
Molecular FormulaC18H14N4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=[N+]([O-])c1ccc(N=Nc2ccc(Nc3ccccc3)cc2)cc1
-
Chemical Name4-((4-Nitrophenyl)diazenyl)-N-phenylaniline
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Salnacedin
Salnacedin (G-201) is a small molecule compound used in the treatment of immune system disorders, skin and musculoskeletal disorders, and can be used in studies of acne vulgaris, dermatitis and psoriasis.
-
Calcitonin, rat
Calcitonin (rat) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development.
-
BRCA1-IN-2
BRCA1-IN-2 is a cell membrane-crossing BRCA1 protein-protein interaction (PPI) inhibitor with antitumor activity that acts by disrupting the interaction of BRCA1 (BRCT)2 with proteins.
Cart
sales@molnova.com